Recurrent oligodendroglioma with changed 1p/19q status

We report a case of oligodendroglioma that had consistent histopathological features as well as a distinct change in 1p/19q status in the second recurrence, after temozolomide chemotherapy and radiotherapy. The first tumor recurrence had oligodendroglial morphology, IDH1 R132H and TERT promoter muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Barresi, Valeria, Mafficini, Andrea, Calicchia, Martina, Piredda, Maria Liliana, Musumeci, Angelo, Ghimenton, Claudio, Scarpa, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546156/
https://www.ncbi.nlm.nih.gov/pubmed/35144313
http://dx.doi.org/10.1111/neup.12789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546156/
https://www.ncbi.nlm.nih.gov/pubmed/35144313
http://dx.doi.org/10.1111/neup.12789

Ejemplares similares